Printed From BioPortfolio.com
Slow-release, once-weekly pill for HIV developed
04:23 EST 10 Jan 2018 | Pharmafile
Patient adherence is a big issue across the healthcare system, where individuals, even with the most serious conditions, do not take medicine as advised.
In the management of HIV through antiretroviral treatment (ART), it is estimated that average adherence is 70% (according to researchers from the University of California). This is a significant worry when treatment with ART requires adherence of 95% and above to be effective.
Image caption:
IMAGE: MIT/Melanie Gonick
Original Article: Slow-release, once-weekly pill for HIV developed
